New data from the ATAC trial, which is testing anastrozole and tamoxifen in early breast cancer, have demonstrated the continued superiority of the aromatase inhibitor. Among other things, the data
GORDON MCVIE, European Institute of Oncology, Milan
In Istanbul, Gordon McVie gave his opinion about the achievements of the 2006 European Society for Medical Oncology Congress. He added his
Carl Christophe Schimanski
Julie Gralow, from the Fred Hutchinson Cancer Research Center in Seattle, joins Derek Thorne to talk about the latest news from the ASCO annual meeting in Atlanta.
– In women with